InvestorsHub Logo
Followers 50
Posts 899
Boards Moderated 0
Alias Born 05/01/2015

Re: None

Monday, 07/27/2015 10:55:53 PM

Monday, July 27, 2015 10:55:53 PM

Post# of 483342
"CM - The outcome of the Phase 2a will determine what the best "ratio" might be if data confirms preclinical findings of synergy with donepezil. Anavex could develop a proprietary new formulation or a standard combination depending on the findings of Phase 2a."

Thoughts about the proprietary formulation?
Volume: 827,536
Day Range: 8.45 - 8.95
Bid: 8.45
Ask: 8.52
Last Trade Time: 7:50:26 PM EST
Total Trades: 10,064
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News